Search Results - "Tao, Yi‐Feng"

Refine Results
  1. 1

    Left Hepatic Vein Preferential Approach Based on Anatomy Is Safe and Feasible for Laparoscopic Living Donor Left Lateral Sectionectomy by Lu, Lu, Wang, Zheng‐Xin, Zhu, Wen‐Wei, Shen, Cong‐Huan, Tao, YiFeng, Ma, Zhen‐Yu, Zhang, Quan‐Bao, Li, Rui‐Dong, Jia, Hu‐Liang, Qin, Lun‐Xiu, Chen, Jin‐Hong

    Published in Liver transplantation (01-01-2021)
    “…We assess the safety and feasibility of the left hepatic vein preferential approach (LHVPA) based on left hepatic vein (LHV) anatomy for living donor…”
    Get full text
    Journal Article
  2. 2

    Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling by Yi, Feng-Tao, Lu, Qi-Ping

    Published in Oncology letters (01-12-2017)
    “…Mucin 1 (MUC1) is aberrantly overexpressed in numerous human cancer types, including hepatocellular carcinoma (HCC) and contributes to chemoresistance of tumor…”
    Get full text
    Journal Article
  3. 3

    Effect of lncRNA‑BC200 on proliferation and migration of liver cancer cells in vitro and in vivo by Tan, Ni, Zhu, Bo, Shu, Hong, Tao, Yi-Feng, Wu, Jun-Rong, Fang, Min, Li, Chun-Rong, Chen, Zhong-Qing, Ou, Chao

    Published in Oncology reports (01-02-2020)
    “…In recent years, the important role of long non‑​coding RNAs (lncRNAs) in the development of liver cancer has received increasing attention. The abnormal…”
    Get full text
    Journal Article
  4. 4

    Identification of Serum Biomarkers for Ischemic Penumbra by iTRAQ‐Based Quantitative Proteomics Analysis by Pang, Xiao‐Min, Zhou, Xia, Su, Sheng‐You, Chen, Chun‐Yong, Wei, Zhi‐Xiao, Tao, YiFeng, Liu, Jing‐Li

    Published in Proteomics. Clinical applications (01-09-2019)
    “…Purpose Ischemic penumbra is the main therapeutic target for acute ischemic stroke. The aim in this study is to investigate the potential serum biomarkers of…”
    Get full text
    Journal Article
  5. 5

    The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma by Li, Jian-Hua, Chen, Tuo, Xing, Hao, Li, Rui-Dong, Shen, Cong-Huan, Zhang, Quan-Bao, Tao, Yi-Feng, Wang, Zheng-Xin

    “…Liver transplantation (LT) is the “cure” therapy for patients with hepatocellular carcinoma (HCC). However, some patients encounter HCC recurrence after LT…”
    Get full text
    Journal Article
  6. 6

    Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models by Cai, Xiao-Jun, Li, Rui-Dong, Li, Jian-Hua, Tao, Yi-Feng, Zhang, Quan-Bao, Shen, Cong-Huan, Zhang, Xiao-Fei, Wang, Zheng-Xin, Jiao, Zheng

    Published in Frontiers in pharmacology (09-11-2022)
    “…Background and Objective: Tacrolimus, a calcineurin inhibitor widely used as a potent immunosuppressant to prevent graft rejection, exhibits nonlinear kinetics…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Integrated multi-omics analysis identifies ENY2 as a predictor of recurrence and a regulator of telomere maintenance in hepatocellular carcinoma by Li, Jian-Hua, Tao, Yi-Feng, Shen, Cong-Huan, Li, Rui-Dong, Wang, Zheng, Xing, Hao, Ma, En-Si, Xue, Hong-Yuan, Zhang, Quan-Bao, Ma, Zhen-Yu, Wang, Zheng-Xin

    Published in Frontiers in oncology (04-08-2022)
    “…Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and has a high recurrence rate. Accurate prediction of recurrence risk is…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients by Zhang, Xiao-Fei, Yang, Xin, Jia, Hu-Liang, Zhu, Wen-Wei, Lu, Lu, Shi, Wei, Zhang, Hao, Chen, Jin-Hong, Tao, Yi-Feng, Wang, Zheng-Xin, Yang, Jun, Wang, Lian-Xin, Lu, Ming, Zheng, Yan, Zhao, Jing, Dong, Qiong-Zhu, Qin, Lun-Xiu

    Published in Cancer biology & medicine (01-12-2016)
    “…Objective: The expression of B-cell lymphoma 2(Bcl-2) seems to be influenced by the endocrine environment. Numerous reports demonstrate the diverse expression…”
    Get full text
    Journal Article
  12. 12

    Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation by Teng, Fei, Wang, Gui-Hua, Tao, Yi-Feng, Guo, Wen-Yuan, Wang, Zheng-Xin, Ding, Guo-Shan, Shi, Xiao-Min, Fu, Zhi-Ren

    Published in World journal of gastroenterology : WJG (21-08-2014)
    “…AIM: To establish a model to predict long-term survival of hepatocellular carcinoma(HCC) patients after liver transplantation(MHCAT).METHODS: Two hundred and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma by Lyu, Wen-Tian, Song, Qi-Bin, Qiong, Wang, Liu, Jing, Yong, Ren, Yi, Feng-Tao, Han, Dong-liang

    Published in Medicine (Baltimore) (07-05-2021)
    “…CD30+ primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a rare T-cell neoplasm, and has been reported to present with an indolent behavior. The…”
    Get full text
    Journal Article
  15. 15

    Formation of Flower-Like Carbon Nanosheet Aggregations and Their Electrochemical Application by Shen, Jian-Min, Feng, Yi-Tao

    Published in Journal of physical chemistry. C (28-08-2008)
    “…We hereby report an easy solvothermal pathway for the large-scale preparation of flower-like carbon nanosheet aggregations (FCNAs) by reacting ferrocene and…”
    Get full text
    Journal Article
  16. 16

    Ex vivo liver resection and auto-transplantation as an alternative for the treatment of liver malignancies: Progress and challenges by Yang, Xin, Lu, Lu, Zhu, Wen-Wei, Tao, Yi-Feng, Shen, Cong-Huan, Chen, Jin-Hong, Wang, Zheng-Xin, Qin, Lun-Xiu

    “…Hepatectomy is still the major curative treatment for patients with liver malignancies. However, it is still a big challenge to remove the tumors in the…”
    Get full text
    Journal Article
  17. 17

    MicroRNA-144 suppresses the expression of cytokines through targeting RANKL in the matured immune cells by Li, Rui-Dong, Shen, Cong-Huan, Tao, Yi-Feng, Zhang, Xiao-Fei, Zhang, Quan-Bao, Ma, Zhen-Yu, Wang, Zheng-Xin

    Published in Cytokine (Philadelphia, Pa.) (01-08-2018)
    “…•The expression of miR-144 was decreased in the matured DCs, macrophages, and PBMCs.•MiR-144 mimics inhibit TNF-α, IL-1β, IL-6 and IL-23 in DCs, and IL-17 in…”
    Get full text
    Journal Article
  18. 18

    Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients by Tao, Yi-feng, Deng, Zeng-fu, Liao, Lin, Qiu, Yu-ling, Chen, Wen-qiang, Lin, Fa-quan

    Published in Annals of hematology (01-05-2015)
    “…The objective of this study is to compare and evaluate the diagnostic value of hereditary spherocytosis (HS) by three screening tests, comparing mean spherical…”
    Get full text
    Journal Article
  19. 19

    Evaluation of a Flow-Cytometric Osmotic Fragility Test for Hereditary Spherocytosis in Chinese Patients by Tao, Yi-Feng, Deng, Zeng-Fu, Liao, Lin, Qiu, Yu-Ling, Deng, Xue-Lian, Chen, Wen-Qiang, Lin, Fa-Quan

    Published in Acta haematologica (01-01-2016)
    “…Osmotic fragility testing based on flow cytometry was recently introduced for the screening of hereditary spherocytosis (HS). This study was undertaken to…”
    Get more information
    Journal Article
  20. 20

    Liver transplant recipients with portal vein thrombosis:a single center retrospective study by Tao, Yi-Feng, Teng, Fei, Wang, Zheng-Xin, Guo, Wen-Yuan, Shi, Xiao-Min, Wang, Gui-Hua, Ding, Guo-Shan, Fu, Zhi-Ren

    “…BACKGROUND:Portal vein thrombosis(PVT)used to be a contraindication for liver transplantation(LT).This obstacle has been delt with following the improvement of…”
    Get full text
    Journal Article